Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes Mellitus

20221 citationsJournal Articlegold Open Access

Authors

Alexander Thomas · Yale University

Dean J. Kereiakes · Christ Hospital

Andreas Baumbach · Queen Mary University of London

Stephan Windecker · University of Bern

Cody Pietras · Yale University

Ovidiu Dressler · Cardiovascular Research Foundation

M. Ozgu Issever ·

Abstract

This prespecified substudy of the PIONEER III trial demonstrated the relative safety and efficacy of the novel Supreme DES when compared with commercially available DP-EES in diabetics at 1 year. Longer term follow-up will be required to ensure continued safety and efficacy of the Supreme DES.

Topics & Keywords

Coronary Interventions and Diagnostics Antiplatelet Therapy and Cardiovascular Diseases Peripheral Artery Disease Management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of the Society for Cardiovascular Angiography & Interventions

Volume 1, Issue 2, pp. 100033-100033

DOI: 10.1016/j.jscai.2022.100033

Field-Weighted Citation Impact: 0.22